Skip to main content

2024

Our Next Pathology Oncology Digital Series

WELCOME

CAMP PODS is a webinar series, consisting of nine one-hour sessions that will take place from February to November 2023 on the 1st Thursday of each month.

The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed.  Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.

Overall Learning Objectives:

By the end of the webinar series, an audience member will:

  1. Establish a strong Oncology Education Network
  2. Compare ideas, thoughts and common challenges
  3. Identify gaps and find team solutions for improving patient care
  4. Integrate pathology and oncology practices

OUR NEXT CAMP PODS SESSION

REGISTER FOR CAMP PODS NOW!
Monday, November 20, 2023
10:00am – 10:45am PST Molecular Pathology of Sarcomas: A Blend of Morphology and Genetics Prof. Dr. Enrique de Álava, Virgen del Rocío University Hospital, Spain
10:45am  – 11:00am PST Questions & Answers
Learning Objectives:

  1. Understand the significant molecular advancements and changes in the classification of sarcomas in the last decade.
  2. Identify the challenges encountered in the diagnostic approach to sarcomas.
  3. Assess the benefits and limitations of routine molecular diagnostic tools such as Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), and Fluorescence In Situ Hybridization (FISH) in sarcoma pathology.

OUR LAST CAMP PODS SESSION

Thursday, Novmeber 20, 2023
10:00am – 10:45am PST Molecular Pathology of Sarcomas: A Blend of Morphology and Genetics Prof. Dr. Enrique de Álava, Virgen del Rocío University Hospital, Spain
11:15am  – 11:30PST Questions & Answers
Learning Objectives:

  1. Understand the significant molecular advancements and changes in the classification of sarcomas in the last decade.
  2. Identify the challenges encountered in the diagnostic approach to sarcomas.
  3. Assess the benefits and limitations of routine molecular diagnostic tools such as Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), and Fluorescence In Situ Hybridization (FISH) in sarcoma pathology.
Close Menu